111 Item Items
Warning: Last items in stock!
Release form, composition and packaging
Pills round flat with a facet and dividing risk on the one hand, white or almost white.
|Clenbuterol Hydrochloride||0.02 mg|
Excipients: lactose monohydrate 70 mg, wheat starch 31.48 mg, microcrystalline cellulose 48.5 mg, colloidal silicon dioxide 2 mg, Magnesium stearate 2 mg, povidone (povidone K25) 6 mg.
Prevention and relief of bronchospasm in bronchial asthma, bronchitis with broncho-obstructive syndrome.
Is taken orally at a dose of 2.5-20 mg 2 times / day. The dose is set depending on the age of the patient and the clinical situation.
Cardiovascular: tachycardia, extrasystole, lowering blood pressure.
From the side of the central nervous system: trembling fingers, anxiety, headache.
Gastrointestinal: dry mouth, nausea.
Allergic reactions: appearance of skin rash.
Thyrotoxicosis, tachycardia, tachyarrhythmia, subaortic aortic stenosis, acute period of myocardial infarction, pregnancy, hypersensitivity to Clenbuterol.
Use during pregnancy and lactation
Contraindicated for use in pregnancy.
Development of resistance and rebound syndrome is possible.
Do not allow contact with the drug in the eye, especially with glaucoma.
Beta-blockers are pharmacological antagonists of clenbuterol and can eliminate its effect.
Clenbuterol reduces the effects of hypoglycemic agents. Increases the risk of developing intracardiac conduction disorders, while the appointment with MAO inhibitors and theophylline. Increases the toxicity of cardiac glycosides and increases the risk of arrhythmias. In combination with sympathomimetic agents, a mutual increase in toxicity occurs.